Is the pharma industry on its ESG game? We asked 49 pharmaceutical and biotech firms, plus 22 contract manufacturing organisations, about the progress they’ve made so far in advancing their environmental, social and governance performance. Among other things, we learned that:
- Companies are going beyond legal requirements for their region
- Social policies are leading the way
- The most mature environmental metrics are in the supply chain
Download the Special Report to learn more and get a detailed insight.
Life Sciences & Pharma
Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives
Digital Excellence in Healthcare and Life Sciences: Riding the Wave of Innovation